Mynaric Receives Nasdaq Deficiency Letter

Mynaric AG has announced receipt of a Deficiency Letter from Nasdaq. This letter was issued because Mynaric's shares failed to meet the Nasdaq minimum closing bid price requirement of $1.00 for 30 consecutive business days. The announcement was made on January 29, 2025.

The letter does not impact the immediate trading of Mynaric’s American Depositary Shares (ADS), which still trade under the symbol "MYNA". Mynaric has until July 22, 2025, to comply with the requirement. Compliance is achieved if the closing bid price meets or exceeds $1.00 for 10 consecutive business days within this period.

If Mynaric fails to comply, it might get an additional 180-day period if certain conditions are met. These include meeting other listing standards and possibly executing a reverse stock split. Mynaric is also addressing previous non-compliances related to market value and reporting requirements.